Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study

To identify markers of non-response to neoadjuvant chemotherapy (NAC) that could be used in the adjuvant setting. Sixteen pathologists of the European Working Group for Breast Screening Pathology reviewed the core biopsies of breast cancers treated with NAC and recorded the clinico-pathological find...

Descripción completa

Detalles Bibliográficos
Autores principales: Balmativola, D., Marchiò, C., Maule, M., Chiusa, L., Annaratone, L., Maletta, F., Montemurro, F., Kulka, J., Figueiredo, P., Varga, Z., Liepniece-Karele, I., Cserni, G., Arkoumani, E., Amendoeira, I., Callagy, G., Reiner-Concin, A., Cordoba, A., Bianchi, S., Decker, T., Gläser, D., Focke, C., van Diest, P., Grabau, D., Lips, E., Wesseling, J., Arisio, R., Medico, E., Wells, C., Sapino, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243004/
https://www.ncbi.nlm.nih.gov/pubmed/25395316
http://dx.doi.org/10.1007/s10549-014-3192-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243004/
https://www.ncbi.nlm.nih.gov/pubmed/25395316
http://dx.doi.org/10.1007/s10549-014-3192-3

Ejemplares similares